The Molecular Pharmaceutics & Drug Delivery Seminar Series Presents:
Dr. Darren Reid, Director Process Development, Drug Product Technologies, Amgen
Staging Innovative Drug Candidates for Success – Molecule Assessment
Thursday, October 19, 2023
1:00 p.m. – 2:00 p.m.
Zoom
Dr. Darren Reid is the Director of the Synthetics Enabling Technologies group in Pre-Pivotal Drug Product Technologies at Amgen and is responsible for synthetics Dev-Molecule Assessment and form selection, end-to-end solid state process support, and synthetics formulation development for preclinical and parental FIH studies. Before joining Amgen, Darren Reid received his Ph.D. in physical organic chemistry from McMaster University and held Postdoctoral positions at the University of Calgary and Pfizer, developing approaches to assess oxidative stability. He has co-authored 30 external articles, reviews, and book chapters, and several patents/applications, including for the LUMAKRAS(R) commercial form. His research interests include drug stability, developability assessment, and formulation strategies. Darren is a founding steering committee member for Lhasa Ltd.’s Zeneth drug degradation prediction program and an active member of ACS and AAPS.